Maxygen Licenses Dengue Vaccine Programme to sanofi pasteur
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 8 Jan-2008
DOI: 10.3833/pdr.v2008.i91.237 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Maxygen entered into licensing agreement with Sanofi Pasteur to develop and commercialize dengue vaccines using Maxygen’s proprietary dengue virus antigen technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS